This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.75% per year. These returns cover a period from January 1, 1988 through July 7, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Procter & Gamble Stock Rises on Q4 Earnings & Sales Beat, Strong View
by Zacks Equity Research
The PG stock climbs after Q4 earnings and sales top estimates, driven by broad segment gains and a strong fiscal 2026 forecast.
P&G (PG) Reports Q4 Earnings: What Key Metrics Have to Say
by Zacks Equity Research
The headline numbers for P&G (PG) give insight into how the company performed in the quarter ended June 2025, but it may be worthwhile to compare some of its key metrics to Wall Street estimates and the year-ago actuals.
Procter & Gamble (PG) Q4 Earnings and Revenues Surpass Estimates
by Zacks Equity Research
P&G (PG) delivered earnings and revenue surprises of +3.50% and +0.39%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?
S&P 500 & Nasdaq Notch New All-Time Closing Highs
by Mark Vickery
Markets lost a bit of steam mid-session this Monday, but a late surge into the close brought the S&P 500 and the Nasdaq indexes to new record closing highs.
Heavy-Duty Earnings Week Commences
by Zacks Equity Research
Heavy-Duty Earnings Week Commences.
Big Week for Jobs, Earnings and the Fed
by Mark Vickery
There's only a 2% chance the Fed has enough votes to cut to outstrip Fed Chair Powell's opinion to keep interest rates where they are.
Procter & Gamble Q4 Earnings Preview: What Should Investors Expect?
by Zacks Equity Research
PG targets modest Q4 and FY25 growth, banking on strong brands, pricing power and cost savings to offset FX, tariffs and China market pressure.
Clorox (CLX) Reports Next Week: Wall Street Expects Earnings Growth
by Zacks Equity Research
Clorox (CLX) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
P&G (PG) Q4 Earnings on the Horizon: Analysts' Insights on Key Performance Measures
by Zacks Equity Research
Evaluate the expected performance of P&G (PG) for the quarter ended June 2025, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Procter & Gamble (PG) Beats Stock Market Upswing: What Investors Need to Know
by Zacks Equity Research
Procter & Gamble (PG) concluded the recent trading session at $158.32, signifying a +2.12% move from its prior day's close.
Procter & Gamble (PG) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
P&G (PG) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Procter & Gamble Company (The) (PG) is Attracting Investor Attention: Here is What You Should Know
by Zacks Equity Research
P&G (PG) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Is It Worth Investing in P&G (PG) Based on Wall Street's Bullish Views?
by Zacks Equity Research
The average brokerage recommendation (ABR) for P&G (PG) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?
Zacks Industry Outlook Highlights Procter & Gamble, Colgate-Palmolive, Church & Dwight and Grocery Outlet
by Zacks Equity Research
PG, CL, CHD, and GO push through margin pressures with innovation, cost control, and digital growth amid tough consumer headwinds.
Can Clorox's Pricing Strength Keep Earnings Buoyant in 2025?
by Zacks Equity Research
CLX leverages targeted pricing, cost cuts and premiumization to boost margins despite soft volume trends.
Procter & Gamble (PG) Stock Sinks As Market Gains: What You Should Know
by Zacks Equity Research
Procter & Gamble (PG) reached $153.76 at the closing of the latest trading day, reflecting a -2.09% change compared to its last close.
4 Resilient Consumer Product Stocks to Watch Amid Market Challenges
by Swati Prasad
Despite rising costs and changing consumer trends, PG, CL, CHD and GO remain resilient, leveraging strategic measures to sustain growth.
Procter & Gamble Company (The) (PG) Is a Trending Stock: Facts to Know Before Betting on It
by Zacks Equity Research
P&G (PG) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Can Colgate's Pricing Strength Keep Earnings Buoyant in 2025?
by Zacks Equity Research
CL's strategic pricing, margin gains and productivity moves support steady EPS growth into 2025 despite cost pressures.
Why Procter & Gamble (PG) Dipped More Than Broader Market Today
by Zacks Equity Research
Procter & Gamble (PG) reached $157.89 at the closing of the latest trading day, reflecting a -1.63% change compared to its last close.
Should You Invest in the Consumer Staples Select Sector SPDR ETF (XLP)?
by Zacks Equity Research
Sector ETF report for XLP
Procter & Gamble (PG) Increases Despite Market Slip: Here's What You Need to Know
by Zacks Equity Research
Procter & Gamble (PG) closed at $161.22 in the latest trading session, marking a +1.19% move from the prior day.
Is Procter & Gamble Set to Shield Earnings From Global Volatility?
by Zacks Equity Research
PG leans on pricing, cost efficiency, productivity and brand strength to protect margins as global volatility clouds earnings outlook.
Investors Heavily Search Procter & Gamble Company (The) (PG): Here is What You Need to Know
by Zacks Equity Research
Zacks.com users have recently been watching P&G (PG) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Is Clorox's International Expansion Key to Its Long-Term Success?
by Zacks Equity Research
CLX bets on global growth as it expands in Latin America and Asia, aiming to offset slowing U.S. sales with long-term international gains.